Biosceptre secures £7m. to boost novel CAR T therapy
Biosceptre today announced the securing of £7m. (US$9.6m.) in funds [...]
Biosceptre boosts Australian biotech capacity with support for new lab
Biosceptre has today announced a partnership with the University of [...]
Cancer Treatment Pioneer to drive New Research in Sydney
Biosceptre’s cancer program established at Westmead Biosceptre (Aust) P/L [...]
Biosceptre Signs Deal With Carina Biotech
Biosceptre is pleased to announce that an agreement has been [...]
Biosceptre attending J.P. Morgan Healthcare Conference in January 2020
Biosceptre will be attending the J.P. Morgan Healthcare Conference, January [...]
Biosceptre Board Changes as result of Sir Gregory Winter’s Nobel Prize
On behalf of Biosceptre we would like to congratulate Sir [...]
Biosceptre wins Gold Medal at China’s largest event for promoting innovation and entrepreneurship
Upon invitation from our lead investor Tuspark S&T, Biosceptre recently [...]
Congratulations to Sir Greg Winter on award of Nobel Prize for Chemistry 2018
Biosceptre congratulates the chair of our Science Advisory Board and [...]
Initiation of Biosceptre’s Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
Biosceptre has initiated its Phase I clinical trial of the [...]
Biosceptre Paper published by Oncogene
A paper describing Biosceptres' recent discoveries of the relationship between [...]